1. Home
  2. CASI vs MHUA Comparison

CASI vs MHUA Comparison

Compare CASI & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • MHUA
  • Stock Information
  • Founded
  • CASI 1991
  • MHUA 1990
  • Country
  • CASI China
  • MHUA China
  • Employees
  • CASI N/A
  • MHUA N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • CASI Health Care
  • MHUA Health Care
  • Exchange
  • CASI Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • CASI 20.5M
  • MHUA 19.6M
  • IPO Year
  • CASI 1996
  • MHUA 2022
  • Fundamental
  • Price
  • CASI $1.40
  • MHUA $0.47
  • Analyst Decision
  • CASI Strong Buy
  • MHUA
  • Analyst Count
  • CASI 1
  • MHUA 0
  • Target Price
  • CASI $4.00
  • MHUA N/A
  • AVG Volume (30 Days)
  • CASI 313.5K
  • MHUA 123.7K
  • Earning Date
  • CASI 08-15-2025
  • MHUA 04-25-2025
  • Dividend Yield
  • CASI N/A
  • MHUA N/A
  • EPS Growth
  • CASI N/A
  • MHUA N/A
  • EPS
  • CASI N/A
  • MHUA 0.40
  • Revenue
  • CASI $31,368,000.00
  • MHUA $96,909,642.00
  • Revenue This Year
  • CASI N/A
  • MHUA N/A
  • Revenue Next Year
  • CASI N/A
  • MHUA N/A
  • P/E Ratio
  • CASI N/A
  • MHUA $1.22
  • Revenue Growth
  • CASI 8.39
  • MHUA N/A
  • 52 Week Low
  • CASI $1.09
  • MHUA $0.25
  • 52 Week High
  • CASI $7.67
  • MHUA $1.47
  • Technical
  • Relative Strength Index (RSI)
  • CASI 44.81
  • MHUA 57.94
  • Support Level
  • CASI $1.23
  • MHUA $0.36
  • Resistance Level
  • CASI $1.50
  • MHUA $0.51
  • Average True Range (ATR)
  • CASI 0.12
  • MHUA 0.05
  • MACD
  • CASI 0.03
  • MHUA 0.00
  • Stochastic Oscillator
  • CASI 78.05
  • MHUA 75.68

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: